Listed

Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2022

Filed with the SEC on May 13, 2022 and accepted by EDGAR at May 13, 2022, 17:23 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-01-01 to 2022-03-31$6.2mus-gaap:Revenues
Cost of revenue3 months2022-01-01 to 2022-03-31$4.5mus-gaap:CostOfRevenue
Gross profit3 months2022-01-01 to 2022-03-31$1.7mus-gaap:GrossProfit
Research and development3 months2022-01-01 to 2022-03-31$73.8kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2022-01-01 to 2022-03-31−$16.4mus-gaap:OperatingIncomeLoss
Income tax3 months2022-01-01 to 2022-03-31−$8.9kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-01-01 to 2022-03-31−$16.6mus-gaap:NetIncomeLoss
Operating cash flow3 months2022-01-01 to 2022-03-31−$2.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2022-01-01 to 2022-03-31$1.4kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-03-31$12.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-03-31$15.0mus-gaap:AssetsCurrent
Total assetsAt period end2022-03-31$83.3mus-gaap:Assets
Current liabilitiesAt period end2022-03-31$8.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-03-31$10.2mus-gaap:Liabilities
Shareholders' equityAt period end2022-03-31$73.1mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001607062-22-000334. Last ingested by Listed: Nov 5, 2026, 16:37 ET. Listed shows no prices and gives no investment advice.